comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-29 23:12:38 - browse：37

New Sanofi Genzyme president Bill Sibold is the first person without any ties to Henri Termeer (inset) to lead the company. Jonathan Wiggs/Globe staff

CAMBRIDGE, Mass. — When drug giant Sanofi restructured its global business two years ago, its Genzyme division got a new name, Sanofi Genzyme, explicitly tying it to the French parent company. It also got new responsibilities and a larger “specialty care” portfolio covering everything from enzyme replacement to cancer and multiple sclerosis drugs.

Last week, Sanofi Genzyme — still the largest Massachusetts biotech, with about 5,000 workers — also got a new president, Bill Sibold. He’s the first one without any ties to the old Genzyme, an independent company that pioneered the rare-disease business model and catalyzed the local life sciences boom before accepting Sanofi’s $20.1 billion takeover offer in 2011.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Risky weight loss products often used by teens globally, per study

hotspot

WSS

Designating disabled people as health disparity population is crucial

New Medicare drug pricing powers could soon be upended in court

HHS names first

AstraZeneca challenges Medicare drug negotiation program

CDC advisory panel says seniors 'may' get RSV vaccine

Feds fine Medicare Advantage plans for overcharging members

knowledge

comprehensive

focus

Moonlake's readout produced a cash windfall. Risks remain

As pharma fights Medicare drug negotiation, hospitals, docs silent

Jerome Adams on the need for new antivirals for Covid

Appeals court upholds limits to abortion pill

Medicare proposal to cover medical devices draws a mixed reaction

How to make Best Hospitals ratings actually useful for patients

As demand for Covid shots wanes, Moderna seeks its next success

Designating disabled people as health disparity population is crucial

Psychedelics group wrestles with new pharma identity

Readout LOUD podcast: live from JPM 2024

hotspot

Complete sequence of Y chromosome published for first time

Risky weight loss products often used by teens globally, per study

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

Generative AI mines health records to identify patients’ social needs

What AAP's gender

Three issues to watch in global health in 2024

entertainment

entertainment

hotspot

hotspot